John P. Butler
CEO and President at Akebia Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Akebia Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Akebia Therapeutics Inc. | Option exercise | +350,000 | $0.63 | $220,500 |
| Mar 4, 2026 | Akebia Therapeutics Inc. | Open-market purchase | +69,270 | $1.25 | $86,588 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Open-market sale | โ46,660 | $1.39 | $64,857 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Open-market sale | โ96,065 | $1.39 | $133,530 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Open-market sale | โ114,891 | $1.39 | $159,698 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Grant or award | +175,250 | $1.41 | $247,103 |
| Feb 2, 2026 | Akebia Therapeutics Inc. | Open-market sale | โ83,689 | $1.39 | $116,328 |
| Jan 30, 2026 | Akebia Therapeutics Inc. | Grant or award | +743,000 | โ | โ |
| Mar 3, 2025 | Akebia Therapeutics Inc. | Open-market sale | โ46,409 | $1.83 | $84,928 |
| Feb 3, 2025 | Akebia Therapeutics Inc. | Open-market sale | โ46,268 | $2.10 | $97,163 |
| Feb 3, 2025 | Akebia Therapeutics Inc. | Open-market sale | โ97,982 | $2.10 | $205,762 |
| Jan 31, 2025 | Akebia Therapeutics Inc. | Grant or award | +701,000 | โ | โ |
| Feb 29, 2024 | Akebia Therapeutics Inc. | Open-market sale | โ46,570 | $1.58 | $73,581 |
| Feb 27, 2024 | Akebia Therapeutics Inc. | Open-market sale | โ37,733 | $1.52 | $57,354 |
| Feb 1, 2024 | Akebia Therapeutics Inc. | Open-market sale | โ46,489 | $1.68 | $78,102 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.